SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.

Ann R. Falsey,Robert W. Frenck,Edward E. Walsh,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,Ruth Bailey,Kena A. Swanson,Xia Xu,Kenneth Koury,Warren Kalina,David A. Cooper,Jing Zou,Xuping Xie,Hongjie Xia,Özlem Türeci,Eleni Lagkadinou,Tompkins Kristin Rachael,Pei-Yong Shi,Kathrin U. Jansen,Ugur Sahin,Philip R Dormitzer,William C. Gruber

SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.

2021

Immune Response to a Third Dose of BNT162b2 A third dose of the BNT162b2 vaccine was administered to 23 volunteers 8 to 9 months after the second dose, and the immune response was assessed. Local r...

Keywords:

severe acute respiratory syndrome coronavirus 2
Immune system
Neutralization
Virology
Medicine
Coronavirus disease 2019
2019 20 coronavirus outbreak

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations